{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"4.500","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"514,584,000","primaryexch":"HKEX","ric":"6978.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BMHKD74","am":"3.45","iv":"","ew_strike":"","as":"4.460","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"4.450","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"1,000","update_time":"2025-09-26 10:38:37.0","lo52":"1.500","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"Tan Zheng","underlying_ric":"6978.HK","hi52":"6.150","issuer_name":"Immunotech Biopharm Ltd. - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"4.340","mkt_cap":"2.29","f_aum_hkd":null,"ew_sub_per_to":"","ls":"4.460","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"+0.110","aum":"","issued_shares_class_B":null,"vo":"782.60","secondary_listing_flag":false,"listing_date":"10 Jul 2020","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Immunotech Biopharm Ltd. - B","nm_s":"IMMUNOTECH-B","sym":"6978","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"Immunotech Biopharm Ltd is an investment holding company primarily engaged in research and development, manufacturing and commercialisation of immune cell products for treatments of cancers. The Company’s non-genetically modified cell product pipeline includes EAL and 6B11-OCIK Injection. The Company’s chimeric antigen receptor T (CAR-T) cell product pipeline includes CAR-T-19 Injection, Denocabtagene Ciloleucel Injection and aT19 Injection. The Company’s T cell receptor engineered T cell therapy (TCR-T) cell product pipeline includes YT003, YT008 and YT007. The Company mainly conducts its business in the domestic market.","op":"4.500","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"31/F, Tower Two<br/>Times Square<br/>1 Matheson Street<br/>Causeway Bay, Hong Kong","pc":"+2.53","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"4.350","isin":"KYG4721A1004","moneyness":""}},"qid":"1758890500607"}
